Firms To Watch: Industry focus: Healthcare and life sciences

Led by Marie Sanchez, NOOA Avocats  advises a range of biotech companies, medical device manufacturers, and pharma groups  on anti-gift rules and the regulatory aspects of clinical research.
Product Law Firm is known for its strength in the full range of matters concerning health products, including promotion and market access. Paul-Henry Deveze leads the practice, and is known for his expertise in criminal health law.

Industry focus: Healthcare and life sciences in France

A&O Shearman

The team at A&O Shearman maintains its reputation for acting in high-profile patent litigation before the French Supreme Court and the Paris First Instance Court involving questions relating to supplementary protection certificates (SPC), the obtaining of preliminary injunctions, and infringement actions against generic companies. On the non-contentious side of the practice, the group regularly advises on M&A and tax structuring mandates. Practice head Laëtitia Bénard is known for her vast expertise in IP, with her primary areas of focus being patent portfolios, patent disputes, and issues concerning price regulation. Promoted to partner in May 2023, Charles Tuffreau has expansive experience in acting for pharma companies in infringement seizures and the securing of monopolies.

Practice head(s):

Laëtitia Bénard

Other key lawyers:

Charles Tuffreau


‘Great team of knowledgeable lawyers. Hard working and fun to litigate with.’

‘Laëtitia Bénard is amazing. Wonderful to work with, witty and well-read, whipping French courts into shape.’

‘Charles Tuffreau follows on behind supporting, strengthening and submitting quality briefs.’

Key clients


ABF Ingredients


Imperial Tobacco (SEITA)

Work highlights

  • Advising a global pharmaceutical and healthcare company on one its blockbusters for the treatment of multiple sclerosis, Gilenya® (fingolimod), having notably initiated preliminary injunction proceedings against several generic companies, based on a patent application covering a second medical use claim, which have now been brought to the Court of Appeal, as well as infringement proceedings on the merits.
  • Advised Ipsen on its entry into exclusive negotiations with the pharmaceutical laboratory Mayoly Spindler in relation to the divestment of its consumer healthcare (CHC) business, including the drugs Smecta®, Forlax®, Tanakan®, Fortrans® and various production sites.
  • Advising ABF Ingredients (ABFI) on the acquisition from various sellers (including ArchiMed), of Fytexia Group, a life science company developing scientifically supported active nutrients for dietary supplements.


ADVANT Altana houses an experienced team which handles the full spectrum of issues relating to international healthcare class actions and IP protection, enforcement, and registration. The group, jointly led by Armand Aviges and Jean-Nicolas Soret, is also acts in high-profile patent infringement actions concerning generics. Aviges is known for representing both domestic and international pharma companies in product liability disputes involving serial claims. Soret has a great deal of expertise advising biotech and medtech players on multijurisdictional private M&A. Gilles Gaillard regularly assists start-ups with a range of corporate financing issues, including joint ventures and partnerships.

Practice head(s):

Armand Aviges; Jean-Nicolas Soret

Other key lawyers:

Gilles Gaillard; Delphine Lapillonne


‘Good collaboration.’

‘Armand Aviges has in-depth knowledge of the pharmaceutical sector in France.’

Key clients



CSRP (Chambre Syndicale de la Répartition Pharmaceutique)














Work highlights

  • Advised PHARMALEX as French local counsel, in connection with the acquisition of PHARMALEX GROUP by AMERISOURCEBERGEN.
  • Advised Italian company LABORATORIO FARMACEUTICO ERFO on its strategic acquisition of 65% of BODYSANO FRANCE, a company specializing in the distribution of food supplements, and aesthetics solutions and diet coaching.

Dechert LLP

Dechert LLP houses a ‘dynamic’ team which advises a number of notable clients, including Roche and Sofinnova. The group displays ‘great’ expertise when handling a broad range of issues, including financings, cases against the French Competition Authority, and the IP aspects of transactions. Alain Decombe and Mélanie Thill-Tayara jointly head the practice. Decombe is known for his deep corporate expertise which spans the negotiation and structuring of share deals, and corporate reorganisations. Thill-Tayara has ample knowledge of antitrust and competition issues, having acted in numerous abuse of dominance and cartel disputes before both EU and French courts. Regulatory specialist Sophie Pelé frequently assists clients with public law-related issues, including contentious market access matters before the administrative supreme court in France.

Practice head(s):

Alain Decombe; Mélanie Thill-Tayara

Other key lawyers:

Jacques Sivignon; Sophie Pelé; Ermine Bolot; Marion Provost


‘A dynamic team, which is up-to-date with the latest news. They have great expertise and strive to satisfy the needs of its customers.’

‘Perfect understanding of the sector and its environment. Very easy contact and mutual trust with the customer.’

Key clients



Cathay Capital

Chiesi Farmaceutici SpA

Havéa Group

HRA Pharma

Mayoly Spindler



Work highlights

  • Represented Roche in its appeal before the Paris Court of Appeal against the €400+m fine initially imposed by the French Competition Authority for an abuse of collective dominance with Novartis. The fine was completely canceled.
  • Advised Abivax on its biotech private placement.
  • Advised Chiesi Farmaceutici SpA on its US$1.4 bn acquisition of Amryt Pharma Plc.


Jointly led by the ‘attentive, extremely professional’ Jean-Marc Grosperrin, Julien Le Guyader, and Anne-Laure Marcerou, the team at Dentons handles the full gamut of issues in life sciences for its diverse client list, including Panasonic, Pfizer, and Laboratoires Servier. Grosperrin is particularly adept at advising global pharma corporations on domestic and cross-border M&A and private equity transactions, while Marcerou is noted for her deep knowledge of the structuring and negotiation of transactions involving biotech and medtech companies. Le Guyader regularly handles market access mandates and issues concerning international tax law. Having joined the team in February 2023 from Dechert LLP, Jessica Garestier exhibits vast regulatory expertise, particularly in relation to market access, promotion, and health product compliance. Pascale Poupelin is a key name of note within the practice, particularly for market access matters.

Practice head(s):

Jean-Marc Grosperrin; Julien Le Guyader; Anne-Laure Marcerou

Other key lawyers:

Olivia Guéguen; Loïc Lemercier; Pascale Poupelin; Jessica Garestier


‘Multidisciplinary and international team. Involved, professional and responsive.’

‘Jean-Marc Grosperrin, very attentive, extremely professional and always able to make himself available.’

‘A responsive, experienced and united team.’

‘The main characteristics of this team include its deep knowledge of the sector, its ability to mobilise, and its proactivity. It is a sufficiently large team but which remains very agile and attentive to its interlocutors.’

Key clients


Adare Pharmaceuticals

Kyowa Kirin Pharma

Laboratoire Coloplast


Al.Chi.mia S.R.L





Dentsply Sirona

Essling Capital



Gojo Industries Inc.

HRA Pharma

Imcheck Therapeutics

IMV Technologies


Kyowa Kirin Pharma

Laboratoires Théa


Medday Pharmaceuticals



Monash University

Ophta France

Orion Corporation



Laboratoires Servier


TBR Dental Group

Work highlights

  • Advising Laboratoires Théa on several matters, including the purchase of R&D assets, the conclusion of a licensing-in agreement with an equity stake in the licensor, and the participation in a financing round in an innovative company.
  • Advised Asabys Partners on the investment by its fund SAHII II (Sabadell Asabys Healthcare Innovation Investments II) in Gradient Denervation Technologies, a Paris-based medical device company developing a minimally invasive solution for the treatment of heart failure patients with pulmonary hypertension, as part of its Series A of €20m.
  • Advised Bpifrance Large Venture on its €30m series A fundraising, together with Eurazeo, in Pharmatech Aqemia to uncover breakthrough drug discoveries at scale.

Hogan Lovells (Paris) LLP

Hogan Lovells (Paris) LLP houses a team which is known for its ‘broad and deep’ experience in contentious life sciences mandates, and its ‘very strong’ expertise in market access issues, data management and protection matters relating to clinical trials, and product liability claims. Notable clients include Eli Lilly, Merck & Co., and GE Healthcare. Practice head Mikael Salmela is noted for his longstanding expertise in handling regulatory assessments and M&A, in addition to product launches and supply transactions. Charlotte Damiano frequently acts for large pharma companies in both contentious and non-contentious matters involving pricing and reimbursement, negotiations with the French health authorities, and the financial regulations governing pharma products.

Practice head(s):

Mikael Salmela

Other key lawyers:

Stanislas Roux-Vaillard; Patrice Navarro; Charlotte Damiano; Charles-Henri Caron


‘Both commercial and practical, and take the time to understand our business, providing excellent advice.’

‘The team has broad and deep experience in life sciences litigation. I have worked with them in cross-border pharmaceutical and vaccine litigation for close to two decades. I find them to be smart, responsive, and collaborative.’

‘Charles-Henri Caron is strategic and a good communicator.’

Key clients

Bristol Myers Squibb / Celgene

Merck & Co., Inc., and its French subsidiary MSD Vaccins

Eli Lilly

Icos Corporation




GE Healthcare



Work highlights

  • Assisted Celgene with a major health data processing authorization request to the CNIL (the French data protection authority) for an innovative drug treatment under a cohort authorization for temporary use (cohort ATU) in France, as well as with the launch and deployment of CAR-T products in France.
  • Assisting Merck & Co., Inc., and its French subsidiary MSD Vaccines in the coordination and defence of product liability claims brought by French plaintiffs before the Courts or before Commissions for Conciliation and Indemnification (CCIs) in relation to alleged adverse events of the vaccine Gardasil.
  • Represented Lilly on the French aspects of generic attacks on its oncology product, Alimta. The court ordered Fresenius Kabi to pay Eli Lilly damages in the amount of EUR 28m, the highest provisional damages award ordered in a life sciences patent dispute in France (and Europe).


IP boutique HOYNG ROKH MONÉGIER handles a broad range of regulatory issues and life cycle management matters, including orphan market exclusivity, pediatric obligations, and pharmacovigilance. Anne Servoir and Benoît Strowel co-lead the team. Servoir is known for her longstanding expertise in acting for pharma and biotech clients in regulatory and competition related matters, while Strowel is a skilled patent litigator who has deep knowledge of bio-pharmaceutical regulatory issues. Patent litigator Sabine Agé primarily focuses on multi-jurisdictional disputes. Agathe Caillé was promoted to counsel in January 2023, having broad experience in disputes concerning packaging and medical devices.

Practice head(s):

Anne Servoir; Benoît Strowel

Other key lawyers:

Sabine Agé; Agathe Caille

Key clients


Ceva Santé Animale

E-health service provider


Institut National de la propriété industrielle


Zheijang Huahai Pharmaceutical

Zimmer Biomet

McDermott Will & Emery AARPI

The ‘competent, trustworthy’ team at McDermott Will & Emery AARPI leverages the firm’s international network to act for a lucrative client base of medical device manufacturers, digital health companies, and investment funds. The group is particularly adept at advising on licensing agreements and partnerships, M&A, and the IP aspects of transactions. Practice head Emmanuelle Trombe is noted for her expansive transactional expertise, regularly advising both French and American biopharma and medical device clients on divestitures and joint ventures. Anthony Paronneau has deep knowledge spanning a broad range of commercial matters, including series funding rounds, fundraisings within the biotech sector, and strategic alliances.

Practice head(s):

Emmanuelle Trombe

Other key lawyers:

Anthony Paronneau; Anne-France Moreau


‘A competent, trustworthy team that is fully available at any time.’

‘Anthony Paronneau has great availability, understanding of the field and the issues, advice and confidence.’

‘Excellent knowledge of the needs of a biotech throughout its lifecycle. Ability to find solutions.’

Key clients

Pierre Fabre

Novo Holdings A/S

Corteria Pharmaceuticals

Biocorp Production SA

Innate Pharma S.A.

TreeFrog Therapeutics

Smart Immune


Five Arrows Principal Investments

Porsolt SAS

DBV Technologies



Cousin Surgery

Dynacure SAS

Newton Biocapital

TransCure bioServices

Relyens Innovation Santé /Turenne Capitaland UI Investissement

Quantis AG

Work highlights

  • Advised Pierre Fabre on the negotiation and conclusion of a collaboration and license agreement with Scorpion Therapeutics to co-develop two next-generation epidermal growth factor receptor (EGFR) inhibitors.
  • Advised Novo Holdings A/S, as well as the other historical investors, on a 130 €M Series C investment in Amolyt Pharma (a clinical stage biotechnology company).
  • Advised Five Arrows Principal Investments on the sale of Hygie31, a major player in the health and wellness sector, to Latour Capital and Bpifrance as minority shareholder.

Simmons & Simmons

Simmons & Simmons continues to maintain its stellar reputation for pharma product liability disputes and arbitrations. The group handles a range of non-contentious mandates, including agreements between medical device manufacturers and healthcare institutions, and the registration of supplementary protection certificates (SPC). Alexandre Regniault leads the team alongside Jacques-Antoine Robert. Antoine-Robert is a specialist in biotech, and stands out due to his longstanding experience in handling large pharma product liability class actions. Regniault is noted for his deep regulatory knowledge, which he utilises to advise on the negotiation and drafting of clinical trial, licensing, and distribution agreements. Ombline Ancelin has a great deal of expertise in handling both contentious and non-contentious competition mandates within the life sciences space.

Practice head(s):

Alexandre Regniault; Jacques-Antoine Robert

Other key lawyers:

Etienne Kowalski; Ombline Ancelin; Simonetta Giordano; Julien Moiroux; Emmanuel Garnier


‘Very good expertise.’

‘This team establishes case law on pharmaceutical product liability. Very easy to contact, we feel the goodwill between them, and the sharing of skills.’

‘The Simmons & Simmons team knows how to identify the key points of files and subjects on which we can mobilise. It is a team that is all the more responsive because it knows how to establish proximity in collaboration with the customer.’

Key clients

Merck Santé

Merck Serono



Rhythm Pharmaceuticals

Bayer Healthcare

Dana – Farber Cancer Institute


Work highlights

  • Assisting Rhythm Pharmaceuticals in relation to the regulatory and data privacy aspects of their activities in Europe, both at EU level (incl. GDPR) and local laws.
  • Assisting Bayer Healthcare within the framework of multi-jurisdictions claims lodged before civil (including two class actions) and administrative courts and before CCI in the context of various pharmaceutical products (a permanently implanted birth control medical device for women, a pharmaceutical products whose active ingredient is cyproterone acetate and oestroprogestative products).
  • Assisting Généthon on strategic licensing projects and have, more specifically this year, assisted with the negotiation and drafting of a collaboration agreement with a Swedish listed company, to develop a pre-treatment to certain gene therapy for patients with anti-AAV antibodies.

Viguié Schmidt & Associés

Viguié Schmidt & Associés is known for exhibiting deep bench strength in handling M&A and disputes, including insider trading investigations, marketing authorisation-related issues, and product liability matters involving vaccines. Praised by clients for his ‘very detailed’ knowledge, practice co-head Etienne Gouesse maintains a litigation focused practice, advising numerous pharma companies on pre-litigation strategy and representing clients before administrative and commercial courts. Co-head Iñaki Saint-Esteben is known for his deep knowledge of competition law, regularly advising clients on merger control and indemnification requests.

Practice head(s):

Etienne Gouesse; Iñaki Saint-Esteben


‘Etienne Gouesse has very detailed knowledge of the legal issues that arise in the context of procedures relating to the liability of defective products applied to medicines and more particularly to vaccines.’

‘A team specialising in post-MA administrative litigation in the life sciences sector.’

‘Etienne Gouesse has great listening skills.’

Key clients

Johnson & Johnson


Work highlights

  • Acted for Johnson & Johnson Santé Beauté France in a private damage claim filed by Carrefour following a decision rendered by the FCA with respect to the home and personal care products industry.On 14 April 2021, the Paris Court of appeal fully dismissed Carrefour’s damage claim (which amounted to more than 10m euros). In its ruling of 19 October 2022, the French Supreme Court definitively rejected Carrefour’s appeal.
  • Acted for AB Science’s CEO in proceeding before the AMF for insider trading. AB Science’s CEO was totally exonerated by the AMF Commission sanction. The AMF’s President appealed.

August Debouzy

With previous experience as French and European patent attorneys, Grégoire Desrousseaux and François Pochart co-lead the ‘professional, available and involved’ practice at August Debouzy. The group frequently represents generic and biosimilar manufacturers, and clients with patented pharma products in contentious matters, with notable clients including Teva, Nipro, and Fresenius Kabi. Desrousseaux regularly represents both French and international clients in FRAND arbitrations and litigation concerning employee inventions, in addition to advising on co-ownership agreements. Pochart acts for clients in patent disputes, and EPO litigation, and opposition before the French IP office (INPI).

Practice head(s):

Grégoire Desrousseaux; François Pochart

Other key lawyers:

Pierre-Olivier Ally; Hélène Billery; Lionel Martin


‘It is a professional, available and involved team. It offers practical solutions adapted to the problems encountered and knows how to adapt its tools to the demands of its customers.’

‘Grégoire Desrousseaux supported us on various issues by providing practical solutions adapted to the health sector and the company’s values.’

‘Francois Pochart and his team are an excellent set of IP advisers. They know their cases inside out and are always looking for innovative solutions.’

‘August Debouzy’s life sciences team is characterised by an excellent technical and legal understanding as well as very good industry knowledge in the life sciences sector. This makes this team really outstanding.’

‘The two leading partners Francois Pochart and Grégoire Desrousseaux are truly exceptional lawyers in the French market. They always advise to the point with a very good understanding of the economic context.’

‘Lionel Martin is a very promising talent with whom it is a pleasure to work on an international level.’

‘Great attention to detail. The team keeps the client very well informed. They understand the law very well and address client questions in a professional manner.’

‘Francois Pochart is excellent. I have worked with Francois over a number of years and he has always provided good, sound advice which is easy to follow.’

Key clients






Disphar (Nordic Pharma Group)


Fresenius kabi



Laboratoires Majorelle





Work highlights

  • Representing Teva in the everolimus dispute against Novartis before the Paris 1st Instance Court. All of the parties have decided to instruct economic experts to prepare reports filed as evidence, where due to revocation of the patent will not be decided.
  • Representing INSULET against one of its competitors (Medtrum) in an infringement action. The firm launched an action on the merits and a preliminary injunction proceeding. A seizure was performed at the home of an employee of the defendant (as the latter has no office in France yet). The PI was granted despite the argument that clinical trials only were on-going, and undertaking that the final products would be changed.

Baker McKenzie

Baker McKenzie houses a ‘fast, reliable and professional’ practice, which is known for its ‘excellent’ expertise in advising global healthcare and biotech corporations on compliance programs, strategic partnerships, and product regulation. Additionally, the group exhibits broad corporate and IP expertise, handling product acquisition arrangements and technology transfer agreements for medtech clients. The ‘exceptionalJulie Yeni leads the team, and frequently advises healthcare clients on both contentious and non-contentious matters, particularly in relation to market access, clinical trials, and commercialisation.

Practice head(s):

Julie Yeni

Other key lawyers:

Katia Boneva-Desmicht; Marie-Françoise Bréchignac; Gilles Jolivet; Magalie Dansac Le Clerc


‘A fast, reliable and professional team, as always. A big plus to have them by our side.’

‘Julie Yeni is recommended for her precision, clairvoyance, and her experience. An exceptional professional.’

‘Accessibility, kindness and adaptability.’

Key clients


BMS – Bristol-Myers Squibb

Johnson & Johnson

Laboratoires Servier

Work highlights

  • Advised New-York-based investment fund New Mountain Capital on the acquisition of the Applied, Food and Enterprise Services (AES) business of the Discovery & Analytical Solutions division of PerkinElmer Inc.
  • Advised Johnson & Johnson, in connection with the spin-out of its consumer healthcare business. In France, this internal reorganization is concretized by notably transferring a manufacturing pharmaceutical establishment from one legal entity to a newly created legal entity within the group.

Bird & Bird

The team at Bird & Bird handles a myriad of issues for its lucrative client base, which notably includes Novo Nordisk, Moon Surgical, and Dexcom. Practice co-head Emmanuelle Porte has deep knowledge spanning a broad range of corporate matters, advising numerous medtech, biotech, and healthcare clients. Co-head Anne-Charlotte Le Bihan is recognised for her longstanding specialism in IP, particularly in relation to patent litigation within the pharma industry. Alexandre Vuchot has a great deal of transactional expertise, often assisting medtech and pharma companies with clinical research, distribution contracts, and procurement arrangements.

Practice head(s):

Emmanuelle Porte; Anne-Charlotte Le Bihan

Other key lawyers:

Ariane Mole; Alexandre Vuchot


‘Alexandre Vuchot is available and efficient, and able to provide us with relevant answers to our questions by surrounding himself with business experts if necessary. A pragmatic and operational approach adapted to the needs and resources of an SME client.

‘Alexandre Vuchot is a dedicated partner. He is available, efficient and pragmatic.’

Key clients


Novo Nordisk


Sparing Vision

Edwards Lifesciences


Moon Surgical








Work highlights

  • Advised Novo Nordisk Region Europe, a Danish multinational pharmaceutical company, in connection with the acquisition of a controlling block trade in Biocorp, followed by a takeover bid and squeeze out on the remaining shares of the company.
  • Representing Edwards Life Sciences in 3 patent infringement actions it has launched against Indian company Meril and its French distributor.
  • Advised Dexcom, a California-based company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management, in relation to a patent infringement case before the Paris local division of the UPC, filed in July 23, against 10 companies of the Abbott Group.

Clifford Chance

The ‘responsive and professional’ team at Clifford Chance exhibits skill across a broad range of areas, including M&A, allegations of abuse of dominance, and employment disputes concerning claims of employer negligence. The group advises a number of notable clients, including Cinven, Sofinnova Partners, and Teva Santé. All co-leading the team, Thomas Baudesson has longstanding expertise in product liability litigation; David Tayar regularly advises clients on merger control investigations, and restrictive arrangements; Dominique Laymand maintains a compliance and ethics focused practice; and Olivier Gaillard focuses on commercial contracts and consumer law issues.

Practice head(s):

Thomas Baudesson; David Tayar; Dominique Laymand; Olivier Gaillard

Other key lawyers:

Laurent Schoenstein; Marianne Pezant


‘Responsive and professional team.’

Key clients

Agria Vet Guide AB


Ares Capital


dsm-firmenich (formerly Royal DSM)

Gland Pharma



Sofinnova Partners


Teva Pharmaceuticals

Teva Santé

Unilabs France

Work highlights

  • Advised private equity firm Cinven on an agreement with Bayer AG to acquire its Environmental Science Professional (BESP) business for a total enterprise value of USD 2.6 bn.
  • Advising Teva on all EU antitrust investigations concerning them, both with respect to allegations of abuse of dominance and anticompetitive agreements, which are currently pending before the Commission or the EU courts.
  • Advising on French veterinary law regulation and practices with a specific focus on veterinary telemedicine.

De Gaulle Fleurance & Associés

De Gaulle Fleurance & Associés houses a broad team which handles the full range of issues concerning competition law, IT, and data protection within life sciences. The team regularly appears before the French administrative courts and the French Competition Authority in disputes concerning marketing authorisations and allegations of abuse of dominant position. Jean-Marie Job, Cécile Théard-Jallu, and Francine Le Péchon-Joubert co-lead the practice. Job is particularly well-versed in mandates involving IT contracts, and both personal and commercial data management. Théard-Jallu is noted for her broad expertise in clinical research projects and technology transfers, while Le Péchon-Joubert regularly advises on trademark portfolio management and joint ventures.

Practice head(s):

Jean-Marie Job; Cécile Théard-Jallu; Francine Le Péchon-Joubert


‘They are especially good in dealing with complex matters at the cross-roads between digital and life sciences. They are used to working on cutting-edge topics.’

‘Cécile Théard-Jallu and Francine Le Péchon-Joubert have very good knowledge of the life sciences sector and a deep understanding of the specific legislation. They are flexible and always available.’

Key clients

Institute For Smart Health




Hoya Surgical GMBH

Delsol Avocats

Noted for its ‘perfect’ mastering of GDPR and health data-related issues, the team at Delsol Avocats frequently handles the setting up of data warehouses, whilst also advising on CNIL authorisations. The group acts in a number of product liability disputes and clinical trials, notably advising networks of biologists, nurses, and physicians, in addition to funds and companies seeking to invest in networks. ‘Extremely competent’ practice head Jeanne Bossi Malafosse is known for her deep expertise in health information systems, particularly in relation to the conditions necessary for accessing health data for medical research purposes, and the new regulations governing the sharing of health data. Gaëlle Merlier has broad contentious expertise, regularly acting in product liability disputes, and advising on health authority inspections, investments into the health care sector, and compliance programmes.

Practice head(s):

Jeanne Bossi Malafosse; Gaëlle Merlier

Other key lawyers:

Bastien Pavec


‘The team is particularly competent, and is recognised in the field of data protection.’

‘Jeanne Bossi Malafosse is extremely competent and collaborative.’

‘The team has perfect mastery of all the regulations surrounding GDPR and health data. Their advice is always pragmatic and allows us to progress.’

‘The team is very professional, available and attentive to its customers. We received very good support for very complex subjects.

‘An efficient, flexible, available team that met our expectations despite a very tight schedule. A very professional collaboration with high added value. ’

‘We are delighted with the support provided by DELSOL’s team, due to its versatility, pragmatism, good understanding of our challenges, and availability.’

‘The team we work with has mastered the regulations relating to the GDPR, particularly as applied to the pharmaceutical/health sector.’

‘Jeanne Bossi Malafosse is very responsive, and gives good advice. We are very satisfied with her analysis. ’

Key clients

Astrazeneca Docaposte


Impact healthcare

CNOP (Conseil National de l’Ordre des Pharmaciens)



Santé Cie







Ipsen Pharma

Ipsen Consumer Healthcare

CNGE (National College of Teaching General Practitioners)

Work highlights

  • Advising Parquest on the healthcare regulatory aspects surrounding the creation of Imaneo, a network of radiologists in the south of France (publication in the LJA).
  • Advising Astrazeneca, Docaposte, Impact Healthcare and Takeda in the implementation of new data bases in the data lake Agoria Santé.
  • Advising Owkin on French and European law, and strategic matters regarding the valorisation of data. The firm is also acting as a partner for Owkin on several multi-jurisdictional studies.

DLA Piper

DLA Piper leverages its international strength to represent its diverse client base, which notably includes Pierre Fabre and Pfizer. Practice head Sonia De Kondserovsky is known for her broad, longstanding expertise, advising on a range of mandates involving clinical trials and industrial agreements, and the transfer of marketing authorisations. Leading the firm’s IP practice, Frank Valentin acts in an array of drug and medical device-related patent disputes. Denise Lebeau-Marianna regularly assists international healthcare and biotech companies with data protection compliance in relation to clinical trials and telemedicine projects. Marion Abecassis acts for a number of key clients in the healthcare space, including contract research organisations and innovative medtech companies.

Practice head(s):

Sonia de Kondserovsky

Other key lawyers:

Denise Lebeau-Marianna; Frank Valentin; Yaël Hirsch; Marion Abecassis


‘Sonia de Kondserovsky and Marion Abecassis are very good at listening and have great availability.’

Key clients

Pierre Fabre

Becton Dickinson



Edwards Lifesciences

Emergent Biosolutions


European Council


Fortive Corp




Laboratoires Vivacy


Nordic Pharma


Qualcomm Life – Capsule




Santen Pharmaceutical




West Pharmaceutical Services


The team at Fieldfisher exhibits deep bench strength across a variety of areas, including the sanctions imposed by regulatory authorities, disputes involving foreign manufacturers, and health data hosting services. Olivier Lantrès leads the team with his longstanding regulatory experience in handling contentious matters concerning phytopharmaceutical products and biological laboratories. IP specialist Nathalie Hadjadj-Cazier has a great deal of expertise in handling urgent protective proceedings and copyright and design litigation before national courts. Marguerite Brac de la Perriere joined the team in August 2023 from LERINS, contributing her knowledge of regulation governing the processing of health data, AI, and the telemedicine.

Practice head(s):

Olivier Lantrès

Other key lawyers:

Nathalie Hadjadj Casier; Franck Veisse; Marguerite Brac de la Perrière


‘The team stands out for its pragmatism, its ability to fully understand the client’s business, and constant preparation.’

‘Very responsive, great ability to think with the client, to be pragmatic and to find solutions. Great creativity. They are technical without losing sight of the big picture.’

Key clients

Recordati Europe

GE Healthcare

Owkin, Inc



Air Liquide



Work highlights

  • Assisting a pharmaceutical company with several aspects, including IT documentation, implementation of the confidentiality policy and GDPR compliance, and impacts of e-prescriptions. The firm is also assisting the client with their regulatory concerns, such as relationships between a commercial company and healthcare professionals, relationships with laboratories, how to deal with the confidentiality, how to share healthcare data, and medical devices.
  • Acted for Recordati in obtaining a favourable decision from the Paris Court of Appeal on 14 April 2023 that rejected the copyright infringement action filed against the client, by its supplier, Alias. The Court rejected all Alias’ claims and ordered it to pay to Recordati legal costs.
  • Advised Affluent Medical on its €6m capital increase in September 2022, and its €13,7m capital increase in March 2023.

Gide Loyrette Nouel A.A.R.P.I.

Gide Loyrette Nouel A.A.R.P.I. is known for its ‘very good’ knowledge of a broad spectrum of issues, advising a varied client roster of dedicated funds, pharma, and medtech and biotech companies. The group exhibits expertise in a whole host of areas, including distribution and marketing, and dealings with the FCA. Raphaëlle Dequiré-Portier primarily focuses on patent and trade mark disputes in France, and across Europe. IP specialist Emmanuel Larere regularly acts in patent disputes, while Arnaud Duhamel has deep transactional expertise, often advising on securities offerings and privatisations. Promoted to partner in July 2023, Paul Jourdan-Nayrac advises various American and European investment funds, and life sciences growth companies.

Practice head(s):

Raphaëlle Dequiré-Portier; Jean-Hyacinthe de Mitry; Emmanuel Larere; Dimitri Dimitrov; Arnaud Duhamel; Anne Tolila

Other key lawyers:

Guilhem Richard; Marie-Ange Pozzo di Borgo; Paul Jourdan-Nayrac


‘Very good knowledge of the subjects and the environment. Expert opinions and advice regarding IP and competition law.’

Key clients


Apollo Global Management

Bristol Myers Squibb

Bryan, Garnier & Co

Cathay Innovation

Dreem SAS


Gensight Biologics

Heal Capital



LifeSci Capital

Meril Life Sciences

Ono Pharmaceutical

Obvious Ventures


Phaxiam Therapeutics

Phoenix Group

SVB Securities

HBC Avocats

Praised for its ‘creativity’ and ‘great’ expertise, the team at HBC Avocats maintains a strong reputation for its capabilities in the negotiation and structuring of the full spectrum of transactions; the group regularly assists clients with contract manufacturing, technology transfer, and clinical trial agreements. Practice co-head Jonathan Burnham primarily advises life sciences companies on the drafting and negotiation of commercial agreements, and is praised for his ‘very strong’ expertise. Erwan Cossé is known for his vast knowledge of M&A and venture capital-related issues, assisting a number of biotech clients.

Practice head(s):

Jonathan Burnham; Erwan Cossé

Other key lawyers:

Fabrice Herbin


‘Very in-depth knowledge of the life sciences sector, ability to negotiate and draft contracts.’

‘Jonathan Burnham is educational, efficient and able to move forward quickly on complex contract markups. Fabrice Herbin has excellent knowledge of the CRO and clinical studies sector. The team is an expert in its field, capable of moving forward quickly and efficiently at a very reasonable cost compared to large structures.’

‘Jonathan Burnham has very strong expertise in contractual matters and intellectual property linked to life sciences. Very technical and specific area of ​​expertise in which Jonathan has shown perfect knowledge and mastery.’

Key clients



Pierre Fabre

Emergence Therapeutics

Onward Therapeutics

OSE Immunotherapeutics


Novasep / Axplora

Vital Meat

Nuntius Therapeutics

Global Antibiotic Research and Development Partnership

Inserm Transfert


Memo Therapeutics

Aleva Neurotherapeutics

Eligo Bioscience


BliNK Biomedical

InFlectis BioScience

Perha Pharmaceuticals




Austral DX

Axess Vision Technology




Luxia Scientific


STH Biotech




Work highlights

  • Advised Emergence Therapeutics, a French and German biotech company, on the drafting and negotiating of a license agreement to obtain access to the Dutch biotech company Synaffix’s proprietary antibody drug conjugate (ADC) technology platform for use with ADC products developed by Emergence.
  • Advised Memo Therapeutics AG, a Swiss biotech company specialised in antibody discovery, on the structuring, drafting and negotiation of a research and development collaboration and license agreement with the Japanese pharmaceutical company Ono Pharmaceutical, aimed at discovering, validating and developing antibodies in the field of immuno-oncology.
  • Advised ESPRIMED, a French company specialized in medical physics and radioprotection, on the structuring, drafting and negotiation of the acquisition of SANTOPTA, a French company specialised in imaging organization consulting, in order to better support medical imaging and nuclear medicine.


Primarily based in Paris, the team of ‘true specialists’ at LexCase handles a broad range of contentious and regulatory matters concerning product liability and health authority decisions. Praised by clients for her ‘unparalleled and in-depth’ healthcare experience, practice co-head Diane Bandon-Tourret is known for her longstanding experience in advising medical device manufacturers and pharma companies on both contentious and non-contentious regulatory matters; while co-head Raphaël Apelbaum advises clients on a range of public health issues, including government audits and public health agency inspections. Working out of the Marseille office, Alain de Belenet is particularly skilled at handling hospital public procurement, and M.A and CE marking-related work, and Maxime Büsch has vast knowledge of litigation concerning public procurement contracts. Victoire Storksen acts for numerous healthcare product manufacturers and distributors in compliance related mandates.

Practice head(s):

Diane Bandon-Tourret; Alain de Belenet; Raphaël Apelbaum; Maxime Büsch

Other key lawyers:

Victoire Storksen


‘Strong industry focus, detailed experience of relevant procedures, network with French Health authorities. ’

‘The practice group is an experienced and well-coordinated team of experts. In particular, Diane Bandon-Tourret’s expertise, excellent accessibility and responsiveness stand out.’

‘Diane Bandon-Tourret stands out for her unparalleled and in-depth expertise in French healthcare. She not only has an excellent network, but is also exceptionally accessible and responsive. It is a pleasure to work with her. ’

‘I particularly appreciate working with Diane Bandont-Tourret and Victoire Storsken for their responsiveness and above all their knowledge of regulations in a complex sector coupled with a real understanding of the company’s commercial, business, marketing and other issues. The consultations are truly tailor-made, which take into account the specificities of companies, their interests and their way of operating. It is not a question of theory, but of practical and achievable support for society.’

‘Knowledge of the health sector. Knowledge of pharmaceutical rules and procedures. Original treatment of cases.’

‘A very attentive team who knows our group perfectly and who always provides high-level advice. The team is innovative in its recruitment of quality employees who are loyal and who are true specialists in the health sector.’

‘Diane and Victoire are particularly attentive and always very responsive. Their work is always at the right level of accuracy and balance.’

‘Very competent and responsive, pragmatic firm, notably, Alain de Bélenet and Maxime Busch in public and administrative law; Diane Bandon-Tourret and Tamara Milano in civil responsibility.’

Key clients



Philips France Commercial

Philips Koninklijke NV

Pierre Fabre Group

Pierre Fabre Dermo-Cosmetique

Pierre Fabre Medicament


Essilor International

Colgate Palmolive



Horizon Therapeutics

Work highlights

  • Advising an international medical devices group on the withdrawal and replacement of life saving devices and other devices worldwide, following the implementation of a full-scale field safety corrective action, in front of competent authorities and French courts, in particular in the context of a major collective action.
  • Assisting several clients of the Conference Bleue Network (mostly US and Asian medical devices manufacturers with EU subsidiaries and pharmaceutic companies) in their discussions with the French Competent Authority (ANSM) to obtain marketing rights for the French market through derogatory proceedings, in close coordination with European law firms.

Norton Rose Fulbright

Marta Giner-Asins leads the team at Norton Rose Fulbright, which advises a diverse client base of biological laboratories, healthcare providers, and international pharma companies. The group handles a number of mandates, including drug market access and pricing, and anti-gift-related matters relating to hospital partnerships. Giner-Asins is noted for her antitrust expertise, having represented numerous pharma companies before both French and European competition Authorities, and in dawn raids. Technology and IP specialist Nadège Martin is noted for her expertise in the creation of health data lakes, in addition to regulatory compliance with CNIL standards, while Christian Dargham handles product liability disputes and investigations. Marion Roquette-Pfister left the firm in early 2024.

Practice head(s):

Marta Giner-Asins

Other key lawyers:

Christian Dargham; Karine Montagut; Nadège Martin


‘The team is relentless in their dedication to their clients. Diverse teams, provided their services with care and were pragmatic.’

Key clients






Ramsay Santé


Work highlights

  • Advised Ramsay Santé as to the eligibility of the debts to be assigned by a pool of circa 50 entities of the group Ramsay Santé for an amount of circa EUR 150m held on the French Health Authorities as part of the COVID-19 revenues compensation scheme put in place by the French Government for the benefit of private acute care groups to such assignment for financing purposes to a private bank (Natixis).
  • Assisted PFIZER France in the negotiations with the French public authorities for the implementation of a new legal system for the marketing, pricing and reimbursement of gene therapies in France.
  • Advised SYNLAB, an international leading group of biological laboratories, in the context of negotiations with the French Social Security Agency regarding invoicing controls and we especially assisted them in drafting a transactional protocol with the French Health Insurance.

Winston & Strawn LLP

Praised for its ‘exceptional quality’, the practice at Winston & Strawn LLP advises a varied client roster consisting of professional organisations, investors into the healthcare sector, and networks of healthcare practitioners. Exhibiting deep transactional expertise, the team regularly advises on private equity investments, corporate issues, and M&A. Practice co-head Gilles Bigot acts for a number of different players in French and European healthcare markets, including laboratories, medical equipment manufacturers, and health institutions in corporate matters. Co-head Julie Vern Cesano-Gouffrant has a great deal of experience in handling both regulatory and transactional matters, including recapitalisations and leveraged buyouts.

Practice head(s):

Gilles Bigot; Julie Vern Cesano-Gouffrant


‘Very attentive to estimating customer needs at all stages of the process.’

‘A relevant mix of knowledge of law, field practice and great creativity to bring new models to the surface.’

‘The Winston team has in-depth expertise in legal vendor due diligence, and in-depth knowledge of the aesthetic medicine sector. Their lawyers are very qualified and experienced in this type of operations. Their approach is both pragmatic and creative, finding tailor-made solutions.’

‘The team is of exceptional quality. Their expertise shines though in finding solutions to address all the issues. All demonstrated exemplary rigor and professionalism in conducting due diligence.’

‘Unique expertise in the health sector, strong links with all stakeholders, true insider partner. The team issues confident recommendations to navigate the regulations and proactively covers all possibilities.’

‘Gilles Bigot has unique expertise and participates in all discussions.’

Key clients






La Croix Rouge Française







Ramsay Générale de Santé

Sarah Santé Group

Abenex Capital SA

Telemos Capital / MedEuropa

Capital Croissance

CRF Jeanne d’Arc

MBO & Co.


Core Equity Holdings


Centres de Médecine Nucléaire


Work highlights

  • Advised the Imapôle group on the acquisition of a minority stake by Eurazeo and Bpifrance.
  • Advised Horadianse SAS on the sale of the majority of its share capital.
  • Assisted the Lazeo group on its partnership with Blackstone.

BCTG Avocats

BCTG Avocats houses a broad team which exhibits deep bench strength across a variety of areas, including distribution strategy, patent infringement actions concerning generics, and partnership contracts. The practice is jointly led by Hugues Villey-Desmeserets, François Dauba, and Gaëlle Bloret-Pucci. Villey-Desmeserets has a great deal of knowledge spanning the drafting and negotiation of commercial contracts and competition related issues, regularly appearing before the FCC and the General Directorate for Fair Trading, Consumer Affairs and Fraud Control (DGCCRF). Bloret-Pucci is an experienced litigator, maintaining an IP and IT focused practice, while Dauba assists clients with sales policy structures and distribution digital transformations.

Practice head(s):

Hugues Villey-Desmeserets; François Dauba; Gaëlle Bloret-Pucci; Séverin Kullmann


‘The team has developed an incredible appetite for business issues, which allows them to perfectly understand the problems of their clients and advise them.’

‘François Dauba benefits from real expertise in the field of pharmaceutical distribution, which he puts to use for the benefit of his clients, providing undeniable added value.’

Key clients

Teva Santé

Stada (EG Labo)

Johnson & Johnson Santé Beauté France


NHCO Nutrition






Work highlights

  • Acted for Teva Santé in proceedings initiated by the DGCCRF before the Correctional Court following an alleged violation of the legal ceiling of discount on invoices, and on the so-called anti-gift law. The firm obtained an acquittal decision on all the grievances
  • Advised Servier on the framework of its international distribution strategy in Eastern Europe, Africa, South America and in the French overseas territories.
  • Advised Iktos, a French company specializing in the development of artificial intelligence solutions applied to the discovery of new treatments, on its series A financing of 15.5m euros with new investors M Ventures and Debiopharm Innovation Fund with the participation of Omnes Capital.


The team at Goodwin maintains its strong reputation for providing ‘high quality’ advice to a broad client base, which notably includes Johnson & Johnson Innovation, Sofinnova Partners, and Kiro. Practice head Anne-Charlotte Rivière is noted for her longstanding expertise in M&A, venture capital, and private equity related issues, having advised on fundraisings and series financing deals. Leading the firm’s IP practice, Marie Fillon is particularly adept at advising on manufacturing and distribution agreements, and R&D. Xavier Leroux joined the team in July 2023 from Bird & Bird, bringing his wealth of expertise in technology.

Practice head(s):

Anne-Charlotte Rivière

Other key lawyers:

Marie Fillon; Thomas Dupont-Sentilles; Xavier Leroux; Louis de Chezelles


‘Very good knowledge of the pharmaceutical/health market.’

‘Marie Fillon and Louis de Chazelle form an extremely responsive team, with great analytical and editorial skills.’

‘Marie Fillon has an excellent understanding of business issues and a good approach to negotiations, both contractually and commercially.

‘Pragmatic approach; listening to the customer and looking for solutions to reach an agreement with the co-contractor’

‘Marie Fillon Marie was able to successfully lead negotiations with a co-contractor who had a less good understanding of market practices for collaboration contracts.’

‘The team demonstrates great professionalism, availability as well as vast experience due to the quality of its members of an office as well as their ability to call on their colleagues in the Goodwin network around the world. The service provided is always of high quality, incorporating current developments relevant to the subject to be discussed.’

‘Marie Fillon – professionalism, availability and expertise.’

‘Marie Fillon is a very sophisticated lawyer on intellectual property and health product licensing matters, responsive and with a very useful commercial vision.’

Key clients

Affluent Medical





Cathay Capital

Cerba Healthcare

DNA Script


DTA Medical

eCential Robotics (former Surgivisio)

EW Healthcare Partners



Graegis Pharmaceuticals

Go Capital

IK Investment Partners

Johnson & Johnson Innovation

Kurma Partners

Lauxera Capital Partners

LBO France



Sofinnova Partners


Vivalto Partners

Herbert Smith Freehills LLP

Herbert Smith Freehills LLP houses a broad practice which leverages its international network to advise high-profile pharma companies. The group handles numerous patent revocation and infringement actions, in addition to preliminary injunction proceedings. Frédéric Chevallier leads the team, and has vast experience in acting in multi-jurisdictional patent cases.

Practice head(s):

Alan Montgomery; Shaun McVicar; Frédéric Chevallier; Laura Orlando

Key clients


Work highlights

  • Advising Sanofi in relation to one of its fastest growing products, Aubagio®, for the treatment of multiple sclerosis (teriflunomide). This has involved one patent revocation action initiated by Teva.
  • Advising Sanofi in relation to one of its fastest growing products, Jevtana®, for the treatment of prostate cancer (cabazitaxel). This has involved three preliminary injunction patent proceedings initiated in France against Teva, Accord Healthcare and Ever Pharma, who committed alleged acts of infringement of Sanofi’s patent rights, one patent revocation action initiated by Accord Healthcare, and three patent infringement actions started against these entities.

Jones Day

Leveraging their European network of offices, Jones Day acts for its lucrative client base on a broad range of IP disputes and transactions. The group regularly advises on IPOs, M&A, and disputes concerning patent infringements and license agreement breaches. Practice co-head and environmental law specialist Françoise Labrousse maintains a strong reputation for handling contentious matters. Co-head Renaud Bonnet is known for his deep knowledge of private equity related issues, and for advising a broad array of technology and life sciences clients, and investors.

Practice head(s):

Francoise Labrousse; Renaud Bonnet

Other key lawyers:

Thomas Bouvet; Armelle Sandrin-Deforge


‘Excellent teamwork in handling life sciences matters.’

Key clients

Institut Pasteur




Eligo Bioscience

Latham & Watkins

The team at Latham & Watkins, praised for its ‘in-depth’ sector knowledge, particularly in relation to innovative technology in the medtech and biotech sectors. Praised by clients for her ‘mastery’ of EU regulation, Eveline Van Keymeulen heads the practice. Having deep knowledge spanning CBD regulatory issues, Van Keymeulen is well-placed to advise clients on cross-border regulatory matters. Jeanne Fabre advises numerous global biotech, medical device, and pharma companies on an array of regulatory issues, including market access, post-market obligations, and clinical trials.

Practice head(s):

Eveline Van Keymeulen

Other key lawyers:

Jeanne Fabre


‘Dynamism, competence and customer focus.’

‘Eveline Van Keymeulen is excellent, both for her precise and relevant analyses of developments in the regulatory environment, and for listening and adapting to client needs.’

‘Highest level team in life sciences. Expert advice, experience and responsiveness.’

‘The team, led by Eveline Van Keymeulen and notably composed of Jeanne Fabre, stands out in particular for its understanding of customer issues, thanks to an analysis and mastery of legal issues without equivalent on the market.’

‘The team stands out for its multidisciplinary expertise covering regulatory matters, clinical trials, marketing and compliance. Their advice is always based on in-depth knowledge of the pharmaceutical, biotechnology and medical device sectors, which allows them to provide comprehensive and practical solutions. I see them as leaders in the field thanks to their ability to navigate complex situations on a European scale.’

‘Eveline Van Keymeulen particularly stands out for her mastery of EU regulatory law. Her ability to solve complex problems in the life sciences is unrivaled. It is also very proactive, allowing companies to anticipate regulatory challenges.’

‘Jeanne Fabre demonstrated excellent business acumen and technical competence. Her knowledge of the dynamics of the healthcare sector, particularly in the regulatory area, makes her a valuable advocate for any company operating in Europe.’

‘These lawyers stand out from their peers with their client-centric approach, in-depth industry knowledge and ability to provide practical, actionable advice.’

Key clients



Air Liquide Santé France

Anne’s Daye (DAYE)



Direct Relief Foundation

EFPIA (European Federation of Pharmaceutical Industries and Associations)


Eli Lilly


European Sperm Bank


Inari Medical


Ironwood Pharmaceuticals

Les Laboratoires Servier

Marinus Pharmaceuticals



ProPharma Group

Resilience Care

ReCor Medical

Swedish Orphan Biovitrum AB

Tempus Labs, Inc.



Work highlights

  • Assisting the European Federation of Pharmaceutical Industries and Associations (EFPIA) in its efforts to collaborate on the revision of the EU pharmaceutical framework, in the context of the European Commission’s Pharmaceutical Strategy for Europe.
  • Assisted Marinus Pharmaceuticals Inc. with obtaining a marketing authorization from the European Commission for Ztalmy®, its innovative medicinal product intended as an adjunctive treatment of epileptic seizures in pediatric patients suffering from a rare disease.
  • Advising BC Partners, an international investment firm, on the acquisition of a majority stake in Havea, the French leader in natural healthcare serving the European market


The group at Magenta exhibits deep expertise in competition law, particularly in relation to the distribution of medical devices and pharma products. Gaël Hichri leads the team; praised by clients for his ‘perfect’ knowledge of life sciences specific competition matters, Hichri regularly acts for clients in cases concerning vertical restraints and anticompetitive practices. Benjamin Jothy joined the team from Norton Rose Fulbright in April 2023, contributing his experience in negotiations with government authorities concerning reimbursement registration and early access programs.

Practice head(s):

Gaël Hichri

Other key lawyers:

Benjamin Jothy


‘The team has a very good understanding of the regulatory environment of the life sciences sector, in addition to competition law and delivers concrete solutions. I also appreciate that the team has a realistic and pragmatic approach in terms of evaluation and risk-taking.’

‘I am in contact with Gaël Hichri, whose great availability and responsiveness I can appreciate in addition to the relevance of the legal analysis. He has very good practical knowledge of the sector and its economic and political subtleties and we can only appreciate his personal commitment and involvement in our files.’

‘This is a firm well known in the market as a leading boutique in competition law. The firm regularly works on issues involving manufacturers or healthcare professionals.’

‘Gaël Hichri is particularly renowned for his good knowledge of the health sector.’

‘A dynamic and technically excellent team.’

‘The particular traits of the team are very responsive, and the particularity of having strong expertise in competition law in the pharmaceutical field. ’

‘The Magenta team, led by Gaël Hichri, is a reference partner in the complex competition issues facing the health industries. The team is particularly responsive, and demonstrates creativity and flexibility allowing it to provide innovative solutions to its clients.’

‘Gaël Hichri has a perfect command of competition law applied to the life sciences sector. His analytical finesse, his practical spirit and his great interpersonal skills make him a reference lawyer in a constantly evolving sector.’

Key clients

Bausch & Lomb



Mercure Avocats

With a strong reputation for its corporate expertise, Mercure Avocats regularly assists pharma companies with strategic contractual matters, including R&D and partnership agreements. Practice c0-head Agathe Simon maintains a corporate law and M&A focused practice, regularly advising on sellers’ warranties and the drafting of acquisition arrangements. François-Maxime Philizot is known for his regulatory expertise, particularly in relation to healthcare products and medical devices.

Practice head(s):

François-Maxime Philizot; Agathe Simon


‘The team has strong expertise in regulatory issues specific to health law.’

‘Agathe Simon and François-Maxime Philizot are outstanding professionals.’

‘François-Maxime Philizot is recommended for his regulatory expertise in health law.’

Key clients

Fondation Ipsen


Sanofi Pasteur

HRA Pharma


Ipsen Pharma


Waterland Private Equity / United Petfood Producers NV

Waterland Private Equity / Accent NV

Waterland Private Equity / Alliance Electronics



Kuehne + Nagel


Tribun Health


Work highlights

  • Assisting Sanofi Pasteur in the negotiation of its EU R&D, commercial and distribution agreements relating to vaccines and in the review of specific issues relating to competition and pharmaceutical aspects.
  • Advised Waterland Private Equity and Alliance Electronics in the acquisition of the French target Edgeflex.
  • Assisting Servier in the negotiation of its R&D and business development agreements.

Pinsent Masons LLP

Jointly led by Emmanuel Gougé, Annabelle Richard, and Jules Fabre, who was promoted to partner in May 2023, the team Pinsent Masons LLP regularly assists clients with understanding UPC rules, whilst advising on medical device regulations and advertising rules. Gougé is known for his longstanding expertise in IP matters, primarily focusing on life sciences and medical device related matters, while Fabre, hailed by clients as a ‘safe pair of hands’, displays vast experience in SPC and patent disputes. Richard is noted for her broad knowledge of IT and GDPR related issues within the healthcare sector.

Practice head(s):

Emmanuel Gougé; Annabelle Richard; Jules Fabre

Other key lawyers:

Virginia de Freitas; Marina Jonon


‘The team are hard-working, diligent and detail-focused.’

‘Jules Fabre is a pleasure to work with. He is very knowledgeable and a safe pair of hands, while at the same time having an easy manner and a commercial nous.’

‘Competence, availability and simplicity.’

Key clients


Accord Healthcare

Teva Pharmaceuticals

Fresenius Kabi SwissBioSim

Insud Pharma


Work highlights

  • Represented Zentiva in the defence of an application for a fast-track preliminary injunction from Novartis against sales of Zentiva’s generic version of a fingolimod, Novartis’ blockbuster multiple sclerosis treatment (Gilenya), on the basis of alleged patent infringement.
  • Represented Accord in a patent litigation (fast-track preliminary injunction and revocation action) against Sanofi in relation to its generic version of Sanofi’s blockbuster prostate cancer treatment Jevtana (cabazitaxel).

Reed Smith

Reed Smith houses a broad practice which handles a myriad of issues concerning competition law, anti-corruption, and regulatory issues concerning the distribution of new drugs. The team is jointly led by Marianne Schaffner, Daniel Kadar, Marc Lévy, and Natasha Tardif. Kadar is a commercial litigation specialist who focuses on regulatory investigations with life sciences and medical device clients, while Lévy primarily acts in antitrust disputes concerning abuse of market power and licensing arrangements. Tardif is adept at advising on merger notifications, and Schaffner is noted for her IP expertise, particularly in relation to IP agreements.

Practice head(s):

Marianne Schaffner; Daniel Kadar; Marc Lévy; Natasha Tardif

Other key lawyers:

Isabelle MacElhone

Taylor Wessing

The team at Taylor Wessing handles an array of matters involving market access schemes, the marketing of orphan drugs, and clinical trial agreements. Practice head and specialist in commercial and competition law Friedel Evelyne advises on merger notifications and acquisitions, often appearing before the European Commission. Marc Schuler maintains an IT-focused practice, in addition to assisting clients with the IP aspects of transactions, while Anne-Juliette De Zaluski predominantly advises on M&A and private equity transactions.

Practice head(s):

Friedel Evelyne

Other key lawyers:

Marc Schuler; Anne-Juliette de Zaluski; Inès Tribouillet

Key clients
















Work highlights

  • Advised LABORATOIRES THEA on the management of the parallel imports within the European Union; definition of the roles and missions of the chief pharmacists and quality managers at the EU level; regulatory issues concerning the coexistence of several product formulations; drafting of the commercial agreements of the client’s subsidiaries with pharmacists’ groups and hospitals at the European level, pursuant to both regulatory provisions and commercial rules.
  • Advised the Japanese Organization for Medical Device Development – SANAMED on use of the interim and derogatory measures of the EU Regulation; a request for a derogation before the French drug/medical devices agency (ANSM) for the marketing of their medical device while awaiting the CE marking to be granted by the notified body; and benefit of the new EU Regulation providing for an extension of the CE marking.
  • Advised PACIRA BIOSCIENCES on the specific French anti-gift provisions and sunshine provisions and in the drafting of the agreements with health care professionals; the declaration and authorisation procedures before the health authorities; and assistance re. the French rules governing the advertising of medical products.

Bignon Lebray

The team at Bignon Lebray regularly assists clients with IP agreements, including licenses and series fundraisings, in addition to representing clients in disputes concerning SPC infringements and unfair competition claims. Working out of the Lyon office, practice head Barbara Bertholet handles the full gamut of IP issues for pharma laboratories, medical device manufacturers, and stakeholders in the e-health sector.

Practice head(s):

Barbara Bertholet

Key clients

Laboratoires Cooper



NG Biotech

Dedienne Santé



Hospices Civils de Lyon (HCL)




Work highlights

  • Advising Yposkesi on IP strategic issues and contract negotiations with pharmaceutical companies and biotechs, such as the negotiation of a collaborative contract with a non-profit pharmaceutical institution for the development of a specific cell bank, including the assignment of the ownership of the results and the intellectual property rights related to these results; and the negotiation of master development services and manufacturing agreements.

Ginestié Magellan Paley-Vincent

Ginestié Magellan Paley-Vincent houses a broad practice which acts for a diverse range of clients, including pharma and medical laboratories, medical repatriation companies, and start-ups focused on innovation. Nathalie Boudet-Gizardin heads the practice; Boudet-Gizardin’s primary area of focus is assisting healthcare professionals with all aspects of their contracts with health organisations, in addition to representing them in disciplinary and criminal proceedings.

Practice head(s):

Nathalie Boudet-Gizardin

Other key lawyers:

Catherine Paley-Vincent


Healthcare and life sciences boutique Intuity handles the full gamut of regulatory matters, including market access and general compliance, whilst also advising on commercial contracts and tenders. The ‘remarkableChristophe Hénin leads the team, and has a great deal of experience in handling negotiations with the European Commission in relation to pharma association agreements. Alain Gorny is particularly adept at representing clients in disputes concerning the advertising of pharma products, in addition to serial litigation claims and recalls.

Practice head(s):

Christophe Hénin

Other key lawyers:

Alain Gorny


‘Christophe Hénin is a very professional, responsive person with a precise and clear response to my requests. I also recommend Intuity to all my colleagues in the pharmaceutical industry.’

‘Very responsive, able to react quickly to situations. Creative in developing an innovative line of defense. Rigorous in the application of procedures and principles.’

‘Christophe Hénin is remarkable for his mastery of the regulatory and legal environment.’

Key clients















Work highlights

  • Representing AstraZeneca before French Courts against allegations in relation to the adverse effects of the Covid-19 Vaccine VAXZEVRIA.
  • Representing an IVD medical device manufacturer in several proceedings involving more than 100 plaintiffs (collective actions).
  • Advising an Europe-based pharmaceutical company on all legal and strategic aspects relating to the market entry of generics for its originator medicinal product.

jasper Avocats

Jasper Avocats handles a diverse range of mandates involving medico-social regulations, regularly representing clients before civil and criminal courts. Practice co-head Olivier Saumon is well-known for representing state compensation funds and health professionals’ associations in disputes, while co-head Céline Roquelle-Meyer handles a broad range of issues, including restructurings and the drafting of professional practice contracts. Jean-François Laigneau is noted for his varied expertise in medical liability, and the regulations governing medical devices and medicinal products.

Practice head(s):

Olivier Saumon; Céline Roquelle-Meyer

Other key lawyers:

Jean-François Laigneau

Work highlights

  • Advising a compensation fund, which indemnifies victims of medical accidents on behalf of the French state. The firm acts against firms defending pharmaceutical companies, healthcare professionals, establishments, or patients.

Lerins & BCW

LERINS handles an array of commercial and regulatory issues for clients, including M&A and reorganisations, and contracts between clinics and practitioners. ‘Strategist and conductorLuc Castagnet leads the team, acting for a diverse range of clients, including investment funds, private healthcare bodies, and practitioners. Castagnet is noted for his expertise in real estate matters within the healthcare sector. Marguerite Brac de la Perriere left the team in 2023.

Practice head(s):

Luc Castagnet

Other key lawyers:

Bertrand Vorms; Bruno Lorit


‘The team offers an exhaustive range of skills in the real estate health field, and are extremely available.’

‘Luc Castagnet is the strategist and conductor.’

‘Bertrand Vorms is the expert in medical relations who always has a solution.’

‘Bruno Lorit is the goldsmith of regulations who never gives up.’

Key clients

VIVALTO Santé Investissement




Vivalto Partners




Centre de radiologie de la Providence

Groupe ELSAN

GHI Le Raincy- Montfermeil

Centre Hospitalier d’Arles

Centre Hospitalier de Troyes

Groupement Hospitalier de Territoire GPNE



Work highlights

  • Advised Vivalto Partners on several acquisitions of Healthcare Targets (RadiologyCenters, Radiotherapy Centers, Healthcare Providers).
  • Advised Parquest (an investment fund) on the acquisition of imaging platforms, the restructuring of an imaging center, and the negotiation of documents between the investor and radiologists.
  • Advised Nucleridis (a group of French and Belgian doctors) on the development and operation of the nuclear medicine center at the Clinic de Flandre. This included a partnership with the Elsan Group for the operation of a PET Scan, the creation of an SAS, a GIE, and a SCCV.

Osborne Clarke

Praised for their ‘incredible’ commercial sense, Osborne Clarke’s team regularly assists clients with medical waste management regulations, and ethics related mandates. Practice head Thomas Devred handles a vast range of issues, including regulatory licenses, supply chain issues, and promotional matters. Justine Pellerin is known for her broad commercial expertise, particularly in relation to commercial relationships and internal investigations. Léa Masson-Boukobza joined the team in April 2023, contributing her experience in advising medical device and pharma companies on anti-gift rules and clinical trials.

Practice head(s):

Thomas Devred

Other key lawyers:

Joanna Peltzman; Justine Pellerin; Léa Masson-Boukobza


‘They have a sense of urgency, very responsive, quality and fast service in interactions. Good service, informs us of trends and developments in the market.’

‘The growing life sciences teams at Osborne Clarke Paris has an incredible commercial sense.’

‘I consider Thomas Devred to be part of my team, he just gets my business and what we need, every time, on time. Exceptional service and advice is the norm.’

Key clients


Act For Health

Work highlights

  • Advsing Grifols on the manufacturing strategy to be implemented for the compliance of drug packaging with the waste and circular economy regulation.
  • Assisting Health (PCM-Trials) with the implementation of contracts with a network of nurses for decentralized clinical trial missions (protocol monitoring outside the hospital, particularly in the homes of trial patients). The firm also advised on the analysis of clinical trial regulations, medical waste management regulations, and ethics rules governing interactions between HCPs and the Life Sciences Industry.

Squire Patton Boggs

Carole Sportes and Valérie Ravit jointly lead the team at Squire Patton Boggs, regularly handling a variety of product liability disputes, often acting for insurers and pharma companies. The team represents clients in criminal trials and investigations, whilst assisting with technical investigations.

Practice head(s):

Carole Sportes; Valérie Ravit

Other key lawyers:

Nora Mazeaud

UGGC Avocats

UGGC Avocats is noted for its broad practice which spans the full spectrum of contentious and regulatory healthcare issues. The group regularly advises on the commercialisation of medical devices and medicines, including labelling issues and product composition. Practice head Sylvie Welsch primarily focuses on disputes involving medical liability, and non-contentious matters concerning health product advertising and distribution. Malka Marcinkowski is particularly adept at advising on pharma laboratories and medical device manufacturers on antitrust investigations and the regulations governing health products.

Practice head(s):

Sylvie Welsch

Other key lawyers:

Malka Marcinkowski; Laure Orange

Key clients

AdBio partners




Centre Hospitalier Universitaire de Guadeloupe

Advent France biotechnology

Innothera Group

Olmix Group




Work highlights

  • Acted for AdBio Partners in their acquisition of French biotech company SynHelix, specialised in DNA synthesis technology,by Belgian group Univercells, specialised in the manufacture and marketing of equipment forthe production of drugs, vaccines and biotreatments.
  • Assisted Tridek-One, a biotech start-up specialising in the research and development of CD31 agonists to restore immune balance, in raising €16 million from new investors Pureos BioVentures, Bpifrance through its InnoBio2 fund, Bioqube Ventures and existing investors AdBio Partners, Advent Life Sciences.
  • Advised ANS (Agence du Numérique en Santé -Digital Health Agency) on the tendering of the new public contract for the connection and management of emergency medical services: advice on the tender, management of the risk of litigation, and legal advice on securing the tender (IT reversibility).